Pay in 4 interest-free payments of $5.42 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
KarasawaSAzumaMKasamaTSakamotoSKabeYImaiTet al
10.1056/NEJMoa1607141 65 MarsoS
Przewlocki R et al
Funding This work was supported by the National Natural Science Foundation of China (32002184 to BW), the ZhiYuan project of Inner Mongolia Medical University (ZY0120025 to LS), and the Key Technology Research, Development and Transformation Projects of Inner Mongolia (2021GG0402 to YD and 2022YFSH0102 to YM)
Over a lifetime, patients treated with tirzepatide were projected to incur costs that were $41,688 lower per patient, while gaining an additional 0.506 QALYs compared with patients receiving semaglutide, thus indicating both longevity and improved quality of life in the model
Tirzepatide is the active ingredient in the injectable medications Mounjaro and Zepbound
US$ 23.77
/assets/images/provider/photos/2805921.jpeg)
US$ 24.32
US$ 23.31
US$ 26.69
US$ 26.50
US$ 25.27
